In this discussion hosted by Kelsey Engvik of the Association of Cannabinoid Specialists (ACS), the focus is on the evolution of cannabis policies in the U.S. and the unmet needs of patients. Special guests include Paul Armentano, Deputy Director of NORML, and Dr. Jordan Tishler, a cannabinoid specialist and president of ACS.
Paul Armentano discusses the dramatic shift in cannabis policies over the last three decades, noting the move from criminalization to regulated medical and recreational cannabis in various states. Dr. Tishler elaborates on the challenges and unintended consequences of the recreational cannabis market overshadowing medical cannabis needs. Both experts emphasize the need for better education for both consumers and healthcare providers to ensure responsible use of cannabis. They also address the impact of evolving cannabis policies on the broader economy and the pharmaceutical industry, highlighting the importance of creating a balanced approach that includes both recreational and medical uses.
The conversation concludes with a call for continued research and education to maximize the therapeutic potential of cannabis while minimizing risks.